PYC flags multiple clinical readouts and clean safety data ahead
PYC says the next 18 months will bring multiple human safety and efficacy readouts across four clinical programs, with its PKD program nearing a transition to registrational studies. It cites clean safety data and a strong funding position.
Upcoming 18 months will see multiple human safety and efficacy readouts across four clinical programs, with the PKD program nearing a pivotal transition to registrational studies.
Clean safety data, organizational expansion, and strong funding position the company for late-stage development and pot…